Illumina is at a pivotal moment, balancing near-term challenges with innovations in multiomics, AI, and proteomics to redefine its growth trajectory. ILMN's planned SomaLogic acquisition and new ...

10X Genomics Inc. sued Illumina Inc., accusing it of infringing patents covering single-cell genetic sequencing and spatial technology. Illumina’s products and systems infringe a total of nine patents ...

This week, the Broad Institute gene-sequencing lab said it read infants’ DNA genomes in less than four hours, cutting an hour off the previous Guinness World Record. The point for investors is that ...

Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...

Illumina is launching a new informatics and artificial intelligence software business aimed at drug developers, with the goal of digesting large-scale DNA sequencing and multi-omics data. The ...

"Illumina has inflicted substantial harm on Element, resulting in lost sales, diminished market share, and reduced profits," counsel for DNA-sequencing company Element Biosciences Inc. alleged in an ...

Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...

Illumina Inc. was sued in federal court by a rival claiming the California biotech uses its monopoly power in the market for DNA-sequencing instruments to stomp out new competitors. Illumina tried to ...

On July 31, 2025, the United States Department of Justice (DOJ) announced a $9.8 million settlement with Illumina, Inc. (Illumina) to resolve alleged False Claims Act (FCA) violations related to ...

Soil microbiome profiling is crucial for understanding microbial diversity and its roles in ecosystem functioning and agricultural productivity. Recent advancements in high-throughput sequencing, ...